Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy.

BACKGROUND Patient-delivered partner therapy (PDPT) is the practice of providing disease-specific antimicrobial agents to patients for delivery to their sex partners. Some partners who receive PDPT may forgo clinical evaluation, resulting in missed opportunities for the diagnosis and treatment of comorbid conditions. METHODS We conducted a review of electronic charts for 8623 individuals attending 4 sexually transmitted disease clinics who were sex partners of patients with selected sexually transmitted infections (STIs). We evaluated the concordance between STIs diagnosed in partners and their reported exposures for which they might have received PDPT. RESULTS Among 3503 female and 4647 heterosexual male partners, 19 (0.4%) of 4716 individuals tested were newly diagnosed with human immunodeficiency virus (HIV) infection, and 61 individuals (0.7%) had syphilis. Pelvic inflammatory disease was diagnosed in 133 women (3.8%). Seventy-two (3.2%) of 2226 female and heterosexual male partners reporting exposure to patients with chlamydial infection had gonorrhea diagnosed. Chlamydial infection or gonorrhea was diagnosed in 81 heterosexual male partners (10.3%) who reported contact with women with trichomoniasis. Among 473 men who have sex with men (MSM; including bisexual men), 13 (6.3%) of 207 tested were newly diagnosed with HIV infection, and 8 (1.7%) had syphilis. Six (6.1%) of 98 MSM reporting exposure to patients with chlamydial infection had gonorrhea diagnosed. CONCLUSIONS Infrequent coinfections in female and heterosexual male partners exposed to patients with chlamydial infection or gonorrhea would not preclude use of PDPT. However, PDPT for male partners of women with trichomoniasis and for MSM requires further study.

[1]  K. Holmes,et al.  Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. , 2005, The New England journal of medicine.

[2]  M. Golden,et al.  Patient-Delivered Partner Therapy for Sexually Transmitted Diseases as Practiced by U.S. Physicians , 2005, Sexually transmitted diseases.

[3]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[4]  M. Hogben,et al.  National survey of doctors’ actions following the diagnosis of a bacterial STD , 2003, Sexually transmitted infections.

[5]  J. Klausner,et al.  Patient-Delivered Therapy for Chlamydia: Putting Research Into Practice , 2003, Sexually transmitted diseases.

[6]  K. Holmes,et al.  Partner Notification for HIV and STD in the United States:: Low Coverage for Gonorrhea, Chlamydial Infection, and HIV , 2003, Sexually transmitted diseases.

[7]  J. Fortenberry,et al.  Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among Women: A Randomized, Controlled Trial , 2003, Sexually transmitted diseases.

[8]  J. S. St. Lawrence,et al.  STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. , 2002, American journal of public health.

[9]  C. Connolly,et al.  A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. , 2002, The Journal of antimicrobial chemotherapy.

[10]  A. Oxman,et al.  A systematic review of strategies for partner notification for sexually transmitted diseases, including HIV/AIDS , 2002, International journal of STD & AIDS.

[11]  K. Holmes,et al.  Partner Management for Gonococcal and Chlamydial Infection: Expansion of Public Health Services to the Private Sector and Expedited Sex Partner Treatment Through a Partnership With Commercial Pharmacies , 2001, Sexually transmitted diseases.

[12]  P. Prabhakar,et al.  Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. , 2001, The West Indian medical journal.

[13]  J. Fortenberry,et al.  Determinants of Persistent and Recurrent Chlamydia trachomatis Infection in Young Women: Results of a Multicenter Cohort Study , 2001, Sexually transmitted diseases.

[14]  K. Holmes,et al.  Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. , 1999, Sexually transmitted diseases.

[15]  T. Farley,et al.  Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. , 1998, Sexually transmitted infections.

[16]  A. van den Hoek,et al.  Partner Referral by Patients With Gonorrhea and Chlamydial Infection: Case‐Finding Observations , 1997, Sexually transmitted diseases.

[17]  T. Eng,et al.  The Hidden Epidemic: Confronting Sexually Transmitted Diseases , 1997 .

[18]  L. Forssman,et al.  Contact Tracing in the Control of Genital Chlamydia Trachomatis Infection , 1991, International journal of STD & AIDS.

[19]  J. Christensen,et al.  A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. , 1981, Acta obstetricia et gynecologica Scandinavica.